These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Management of the relapsed/refractory myeloma patient: strategies incorporating lenalidomide. Richardson P Semin Hematol; 2005 Oct; 42(4 Suppl 4):S9-15. PubMed ID: 16344100 [TBL] [Abstract][Full Text] [Related]
3. Lenalidomide and its role in the management of multiple myeloma. Falco P; Cavallo F; Larocca A; Liberati AM; Musto P; Boccadoro M; Palumbo A Expert Rev Anticancer Ther; 2008 Jun; 8(6):865-74. PubMed ID: 18533796 [TBL] [Abstract][Full Text] [Related]
4. Thalidomide and lenalidomide in the treatment of multiple myeloma. Kumar S; Rajkumar SV Eur J Cancer; 2006 Jul; 42(11):1612-22. PubMed ID: 16750621 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic use of immunomodulatory drugs in the treatment of multiple myeloma. Raje N; Hideshima T; Anderson KC Expert Rev Anticancer Ther; 2006 Sep; 6(9):1239-47. PubMed ID: 17020458 [TBL] [Abstract][Full Text] [Related]
6. Lenalidomide in multiple myeloma. Thomas SK; Richards TA; Weber DM Best Pract Res Clin Haematol; 2007 Dec; 20(4):717-35. PubMed ID: 18070715 [TBL] [Abstract][Full Text] [Related]
7. Treatment of multiple myeloma: an emphasis on new developments. Kyle RA; Vincent Rajkumar S Ann Med; 2006; 38(2):111-5. PubMed ID: 16581696 [TBL] [Abstract][Full Text] [Related]
8. Lenalidomide in the treatment of multiple myeloma: a review. Armoiry X; Aulagner G; Facon T J Clin Pharm Ther; 2008 Jun; 33(3):219-26. PubMed ID: 18452408 [TBL] [Abstract][Full Text] [Related]
9. Future drug developments in multiple myeloma: an overview of novel lenalidomide-based combination therapies. Morgan G Blood Rev; 2010 Nov; 24 Suppl 1():S27-32. PubMed ID: 21126634 [TBL] [Abstract][Full Text] [Related]
13. [New treatment strategy of multiple myeloma for cure]. Murakami H; Handa H Gan To Kagaku Ryoho; 2006 Apr; 33(4):417-23. PubMed ID: 16612147 [TBL] [Abstract][Full Text] [Related]
14. Thalidomide and lenalidomide in multiple myeloma. Mazumder A; Jagannath S Best Pract Res Clin Haematol; 2006; 19(4):769-80. PubMed ID: 16997182 [TBL] [Abstract][Full Text] [Related]
15. Lenalidomide: an update on evidence from clinical trials. Dimopoulos MA; Terpos E Blood Rev; 2010 Nov; 24 Suppl 1():S21-6. PubMed ID: 21126633 [TBL] [Abstract][Full Text] [Related]
16. Treatment of multiple myeloma in the targeted therapy era. Saad AA; Sharma M; Higa GM Ann Pharmacother; 2009 Feb; 43(2):329-38. PubMed ID: 19193585 [TBL] [Abstract][Full Text] [Related]
17. Evolving role of novel agents for maintenance therapy in myeloma. Magarotto V; Palumbo A Cancer J; 2009; 15(6):494-501. PubMed ID: 20010169 [TBL] [Abstract][Full Text] [Related]
18. Thalidomide in the treatment of multiple myeloma. Rajkumar SV Expert Rev Anticancer Ther; 2001 Jun; 1(1):20-8. PubMed ID: 12113124 [TBL] [Abstract][Full Text] [Related]
19. Review of therapy for relapsed/refractory multiple myeloma: focus on lenalidomide. Mariz JM; Esteves GV Curr Opin Oncol; 2012 Jan; 24 Suppl 2():S3-11. PubMed ID: 22245806 [TBL] [Abstract][Full Text] [Related]